Company Data
Sonnet BioTherapeutics Holdings Inc.
Ticker
SONN
Current Price
$9.64 86.46%
Market Cap
$30.5M
Price Target
Refer to Report
Volume
44.4M
52wk Range
$1.08 - $10.02
Overview
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm’s pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.